drugset
drugset / Trial / NCT02605655

Clinical Trial of Chinese Formula AMP-1915 on Metabolic Syndrome

NCT02605655 ↗

Phase 0 Completed 60 enrolled Shanghai University of Traditional Chinese Medicine
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether the Chinese formula AMP-1915 has effect on Metabolic Syndrome (MS) in MS patients. Half of patients received AMP-1915, while the other half received placebo.

Timeline

Start
2014-06
Primary completion
2014-12
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject AMP-1915 Unknown 2 g —

Indications

metabolic syndrome X